According to a recent market survey conducted by Future Market Insights (FMI), the global Lung Cancer Surgery Market was valued at US$ 1.23 billion in 2021 and is expected to reach US$ 1.98 billion by 2029.
Robotic thoracic surgery would remain highly preferred over traditional surgical techniques, as it offers higher magnification, more precision, and eliminate the need for large-incision operations. The development of new surgical robots may cut down the cost of devices and increase the shift towards robotic lung cancer surgery.
The introduction of new imaging techniques for enhancing visualization, angled lenses for enhanced accessibility, and end staplers will continue to enhance the video-assisted lung cancer surgery procedure.
Lung Tumor Surgery is a surgical procedure used to remove cancerous cells or tumors from the lungs. Surgery is a common treatment for early-stage lung cancer, and it can also be used in combination with other treatments, such as chemotherapy or radiation therapy, for more advanced stages of lung cancer.
Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-396
Intuitive Surgical is the sole player in robotic lung cancer surgery market with its DaVinci system. Medtronic and Johnson & Johnson are developing surgical robots and are challenging the monopoly of Intuitive Surgical in lung cancer surgery market.
Key Takeaways – Lung Cancer Surgery Market Study
- Introduction of powered and tissue-specific endoscopic stapling technology provides significant benefits to reduce cost, resource usage, improve clinical outcome compared to manual staplers.
- In September 2022, Johnson & Johnson launched ECHELON CIRCULAR
Powered Stapler for thoracic, colorectal, and gastric surgery. - In March 2016, Intuitive Surgical Inc. got U.S. FDA approval for its da Vinci Xi Endowrist Stapler 30 (30 mm) instruments and reloads.
- Key market players are focusing on the development of new robot-assisted thoracic surgery system. Partnerships & collaborations with best in class surgical device and visualization technology developers are the strategic focus of manufacturers. For instance,
- Medtronic partnered with Karl Stroz, a best in class endoscopic imaging devices manufacturer. In June 2022, Medtronic announced its upcoming robotic-assisted surgical platform including three-dimensional vision systems from Karl Stroz.
- East Asia is expected to be the prominent region in the lung cancer surgery market during the forecast year. This is attributed to high prevalence of lung cancer in China & Japan increasing the demand for lung cancer surgery. According to the International Agency for Research on Cancer, from overall cancer patients in China and Japan, around 18.1% and 16.8% patients respectively were having lung cancer.
- In September 2022, Johnson & Johnson launched ECHELON CIRCULAR
Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-396
Development in robotic thoracic surgery platforms and innovation in tissue-specific endoscopic stapling and vessel sealing techniques to reduce endoleak complications will further broaden the growth prospects of the lung cancer surgery market.
Product Portfolio Expansion to Increase Global Footprint
Manufacturers are adopting product portfolio expansion strategy to increase their footprint in the global lung cancer surgery market. Market players such as Pentax Medical, Olympus, Johnson & Johnson, Intuitive Surgical Inc. are continuously focusing on new product launches and regulatory approvals. For instance,
- In July 2016, PENTAX Medical launched new DEFINA high-definition pulmonology endoscopy system for crystal clear imaging during surgical procedures.
- In April 2018, Intuitive Surgical Inc. received U.S. FDA clearance for da Vinci Vessel Sealer Extend single-use, the fully wristed bipolar electrosurgical instrument for lung cancer surgery procedures such lobectomy, segmentectomy, and wedge resection.
Use promo code ->> FMITODAY to get a flat 20% discount
Lung Cancer Surgery Market by Category
By Product:
- Thoracoscopes
- Mediastinoscopes
- Bronchoscopes
- Robotic-Assisted Thoracic Surgery Systems
- Surgical Staplers
- Surgical Energy Instruments
- Advanced Energy Instruments
- Advanced Bipolar Instruments
- Ultrasonic Instruments
- Basic Energy Instruments
- Bipolar Instruments
- Monopolar Instruments
- Advanced Energy Instruments
By Application:
- Lobectomy
- Segmentectomy
- Wedge Resection
- Pneumonectomy
By End-User:
- Hospitals
- Ambulatory Surgical Centers
Have a Look at Related Research Reports of Healthcare Domain:
- https://stemfemmes.mn.co/posts/wheelchairs-market-is-expected-to-reach-us-79-billion-by-2032-fmi
- https://jaydip12.fitnell.com/57172648/wheelchairs-market-is-expected-to-reach-us-7-9-billion-by-2032-fmi
- https://jaydip.ka-blogs.com/70205095/wheelchairs-market-is-expected-to-reach-us-7-9-billion-by-2032-fmi
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
